Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Johnson & Johnson’s Centocor Withdraws Trabectedin Application
Johnson & Johnson’s Centocor Withdraws Trabectedin Application
Johnson & Johnson’s Centocor Withdraws Trabectedin Application
Submitted by
admin
on April 30, 2011 - 10:04am
Source:
Bloomberg
News Tags:
JNJ
Janssen Biotech
Trabectedin
ovarian cancer
Headline:
Johnson & Johnson’s Centocor Withdraws Trabectedin Application
Do Not Allow Advertisers to Use My Personal information
